Advertisement

MMW - Fortschritte der Medizin

, Volume 161, Issue 15, pp 54–65 | Cite as

Akutbehandlung, Diagnostik und Nachsorge

Anaphylaxie — handeln Sie schnell und nachhaltig!

  • Johannes RingEmail author
  • Andreas Weins
  • Martine Grosber
  • Knut Brockow
FORTBILDUNG . ÜBERSICHT
  • 639 Downloads

Zusammenfassung

Auch wenn anaphylaktische Reaktionen in der Hausarztpraxis eher selten sind, erfordern sie ein effizientes Eingreifen. Wie Sie im Ernstfall am besten vorgehen und woran Sie nach Bewältigung der Akutsituation denken sollten, erfahren Sie in diesem Beitrag.

Anaphylaxis — how to act fast and sustainable

Keywords

Anaphylaxis allergy adrenaline epinephrine shock treatment education 

Literatur

  1. 1.
    Johansson SG, Bieber T, Dahl R et al. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol. 2004;113:832–6CrossRefPubMedGoogle Scholar
  2. 2.
    Ring J (ed). Anaphylaxis. Karger, Basel 2010Google Scholar
  3. 3.
    Muraro A, Roberts G, Worm M, Bilo MB, Brockow K, Fernandez Rivas M et al Anaphylaxis: guidelines from the European academy of Allergy and Clinical Immunology. Allergy. 2014;69:1026–45CrossRefPubMedGoogle Scholar
  4. 4.
    Simons FE, Ardusso LR, Dimov V et al. World Allergy Organization Anaphylaxis Guidelines: 2013 update of the evidence base. Int Arch Allergy Immunol. 2013;162:193–204CrossRefGoogle Scholar
  5. 5.
    Portier P, Richet C. De l’action anaphylactique de certains venins. C R Soc Biol. 1902;54:170Google Scholar
  6. 6.
    Bergmann KC, Ring J (eds). History of Allergy. Karger, Basel 2014Google Scholar
  7. 7.
    Moneret-Vautrin DA, Morisset M, Flabbee J, Beaudouin E, Kanny G. Epidemiology of life-threatening and lethal anaphylaxis: a review. Allergy. 2005;60:443–51CrossRefPubMedGoogle Scholar
  8. 8.
    Panesar SS, Javad S, de Silva D, Nwaru BI, Hickstein L, Muraro A, Roberts G, Worm M et al. The epidemiology of anaphylaxis in Europe: a systematic review. Allergy. 2013;68:1353–61CrossRefPubMedGoogle Scholar
  9. 9.
    Sheik A, Alves B. Hospital admissions for acute anaphylaxis: time trend study. BMJ. 2000;320: 1441CrossRefGoogle Scholar
  10. 10.
    Worm M, Eckermann O, Dölle s, Aberer QW, Beyer K, Hawranek T, Hompes s, Koehli A, Mahler V, Nemat K, Nioggemann B, Pfähler C, Rabe U, Reissig A, Rietschel E, Scherer K, Treudler R, Rueff F. Triggers and treatment of anaphylaxis: an analysis of 4000 cases from Germany, Austria and Switzerland. Dtsch Ärztebl Int. 2014;111:367–75PubMedPubMedCentralGoogle Scholar
  11. 11.
    Lee S, Hess EP, Lohse C, Gilani W, Chamberlain AM, Campbell RL. Trends, characteristics and incidence of anaphylaxis in 2001 – 2010: A population-based study. J Allergy Clin Immunol. 2017;130:182–8CrossRefGoogle Scholar
  12. 12.
    Worm M, Edenharter G, Rueff F et al. Symptom profile and risk factors of anaphylaxis in Central Europe. Allergy. 2012;67:691–8CrossRefPubMedGoogle Scholar
  13. 13.
    Hompes S, Dölle S, Grünhagen J, Grabenhenrich L, Worm M. Elicitors and co-factors in food-induced anaphylaxis in adults. Clin Transl Allergy. 2013;3:38–44CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Ring J, Beyer K, Biedermann T, Bircher A et al. Leitlinie zu Akuttherapie und Management anaphylaktischer Reaktionen. Allergo J Int. 2014;23:96–112CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Weins AB, Eberlein B, Biedermann T. Diagnostics of alpha-gal syndrome: Current standards, pitfalls and perspectives. Hautarzt. 2019;70:36–43CrossRefPubMedGoogle Scholar
  16. 16.
    Stark BJ, Sullivan TJ. Biphasic and protracted anaphylaxis. J Allergy Clin Immunol. 1986;78:76–83CrossRefPubMedGoogle Scholar
  17. 17.
    Kim TH, Yoon SM, Lee SY, Choi YM, Park CM, Kan HR, Choo SH. Biphasic and protracted anaphylaxis to iodinated contrast media. Eur radiol. 2018;28:1242–52CrossRefPubMedGoogle Scholar
  18. 18.
    Rohacek M, Edenhofer H, Bircher A, Bingissen R. Biphasic anaphylactic reaction: occurrene and mortality. Allergy. 2014;69:791–7CrossRefPubMedGoogle Scholar
  19. 19.
    Kalesnikoff J, Galli SJ. Anaphylaxis: mechanisms of mast cell activation. Chem Immunol Allergy. 2010;95:45–66CrossRefPubMedGoogle Scholar
  20. 20.
    Genovese A, Rossi FW, Spadaro G, Galdiero MR, Marone G. Human cardiac mast cells in anaphylaxis. Chem Immunol Allergy. 2010;95:98–109CrossRefPubMedGoogle Scholar
  21. 21.
    Pumphrey RSH, Roberts ISD. Postmortem findings after fatal anaphylactic reactions. J Clin Pathol. 2000;53:273–6CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Pumphrey R. Anaphylaxis: can we tell who is at risk of a fatal reaction? Curr Opin Allergy Clin Immunol 2004;4: 285–90.CrossRefPubMedGoogle Scholar
  23. 23.
    Commins SP, Platts-Mills TA. Anaphylaxis syndromes related to a new mammalian cross-reactive carbohydrate determinant. J Allergy Clin Immunol. 2009;124:652–7CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Willi Rl, Pfab F, Huss-Marp J, Buters JT, Zilker T, Behrendt H, Ring J, Darsow U. Contact anaphylaxis and protein contact dermatitis in a cook handling chicory leaves. Contact Dermatitis. 2009;60:226–7CrossRefPubMedGoogle Scholar
  25. 25.
    Fleischer DM, Greenhawt M, Sussman G, Bégin P, Nowak-Wegrzyn A, Petroni D, Beyer K6, Brown-Whitehorn T, Hebert J, Hourihane JO, Campbell DE, Leonard S, Chinthrajah RS, Pongracic JA, Jones SM, Lange L, Chong H, Green TD, Wood R, Cheema A, Prescott SL, Smith P, Yang W, Chan ES, Byrne A, Assa’ad A, Bird JA, Kim EH, Schneider L, Davis CM, Lanser BJ, Lambert R, Shreffler W. Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut Allergy: The PEPITES Randomized Clinical Trial. JAMA. 2019 doi:  https://doi.org/10.1001/jama.2019.1113 [Epub ahead of print].
  26. 26.
    Wölbing F, Fischer J, Köberle M, Karlen J, Biedermann T. About the role and underlying mechanisms of cofactors in anaphylaxis. Allergy. 2013;68:1085–92CrossRefPubMedGoogle Scholar
  27. 27.
    Zink A, Ring J, Brockow K. Kofaktorgetriggerte Nahrungsmittelanaphylaxie. Allergologie. 2014;37:258–64CrossRefGoogle Scholar
  28. 28.
    Niggemann B, Beyer K. Factors augmenting allergic reactions. Allergy. 2014;69:1582–7CrossRefPubMedGoogle Scholar
  29. 29.
    Nassiri M, Babina M, Dölle S, Edenharter G, Rueff F, Worm M. Ramipril and metoprolol intake aggravate human and murine anaphylaxis: evidence for direct mast cell priming. J Allergy Clin Immunol. 2015;135:491–9CrossRefPubMedGoogle Scholar
  30. 30.
    Lang D. Anaphylactoid and anaphylactic reations: Hazards of beta-blockers. Drug Safety. 1995;12:299–304CrossRefPubMedGoogle Scholar
  31. 31.
    Sturm GJ, Varga EM, Roberts G, Mosbech HM, Bilò MB, Akdis CA, Antolín-Amérigo D, Cichocka-Jarosz E, Gawlik R, Jakob T, Kosnik M, Lange J, Mingomataj E, Mitsias DI, Ollert M, Oude Elberink JNG, Pfaar O, Pitsios C, Pravettoni V, Ruëff F, Sin BA, Agache I, Angier E, Arasi S, Calderón MA, Fernandez-Rivas M, Halken S, Jutel M, Lau S, Pajno GB, van Ree R, Ryan D, Spranger O, Gerth van Wijk R, Dhami S, Zaman H, Sheikh A, Muraro A. EAACI Guidelines on Allergen Immunotherapy: Hymenoptera venom allergy. Allergy 2018;73:744–64CrossRefPubMedGoogle Scholar
  32. 32.
    Worm M, Francuzik W, Renaudin JM, Bilo MB, Cardona V, Scherer Hofmeier K, Köhli A, Bauer A, Christoff G, Cichocka-Jarosz E, Hawranek T, Hourihane JO’, Lange L, Mahler V, Muraro A, Papadopoulos NG, Pföhler C, Poziomkowska-Gêsicka I, Ruëff F, Spindler T, Treudler R, Fernandez-Rivas M, Dölle S. Factors increasing the risk for a severe reaction in anaphylaxis: An analysis of data from The European Anaphylaxis Registry. Allergy. 2018;73:1322–30CrossRefPubMedGoogle Scholar
  33. 33.
    Brockow K, Jofer C, Behrendt H, Ring J. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy. 2008;63:226–32CrossRefPubMedGoogle Scholar
  34. 34.
    Scherf KA, Brockow K, Biedermann T, Koehler P, Wieser H. Wheat-dependent exercise-induced anaphylaxis. Clin Exp Allergy. 2016;46:10–20CrossRefPubMedGoogle Scholar
  35. 35.
    Morita E, Chinuki Y Takahashi H, Nabika T, Yamasaki M, Shiwahu K. Prevalence of wheat allergy in Japanese adults. Allergol Int. 2012;61:101–5CrossRefPubMedGoogle Scholar
  36. 36.
    Nolan JP, Soar J, Zideman DA et al. European Resuscitation Council Guidelines for Resuscitation 2010 Section 1. Executive summary. Resuscitation. 2010;81:1219–76CrossRefPubMedGoogle Scholar
  37. 37.
    Deutscher Rat für Wiederbelebung (Hsg). Reanimation 2015 — Leitlinie kompakt 2015:132–3Google Scholar
  38. 38.
    Smith GCS, Pell JP. Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trial. BMJ 2003;327:20–7Google Scholar
  39. 39.
    Westfall und Westfall 2012. Adrenergic agonists and antagonists. In: Goodman Gilman’s pharmacological basis of therapeutics (Hardman JG et al eds). Mc Graw Hill, New York 2013: 277–333Google Scholar
  40. 40.
    Simons FE, Roberts JR, Gu X, Simons KJ. Epinephrine (adrenaline) in anaphylaxis. Chem Immunology Allergy. 2010;95:201–10CrossRefGoogle Scholar
  41. 41.
    Ring J, Brockow K, Kugler C, Gebert N, Grando K, Götz D, Hutegger I, Lüthi H, Münch M, Spindler T, Schmid-Grendelmeier P, Gieler G. Neue Aspekte zur Allergie-Edukation: Beispiel Anaphylaxie. Allergo Journal. 2017;16:33–40Google Scholar
  42. 42.
    Simons FE, Gu X, Simons KJ. Epinephrine absorption in adults: intramuscular versus subcutaneous injection. J Allergy Clin Immunol. 2001;108:871–3CrossRefPubMedGoogle Scholar
  43. 43.
    Perkins GD, Olasveengen TM, Maconochie I, Soar J, Wyllie J, Greif R, Lockey A, Semeraro F, van de voorde P, Lott C, Monsieurs KG, Nolan JP, European resuscitation Council Guidelines for Resusitation: 2017 update. Resuscitation. 2018;123:43–50CrossRefPubMedGoogle Scholar
  44. 44.
    Timmermann A, Böttiger BW, Byhahn C, Dörges V, Eich C, Gräsner JT, Hoffmann F, Hossfeld B, Landsleitner B, Piepho T, Noppens R, Russo SG, Wenzel V, Zwißler B, Bernhard M. AWMF Leitlinie 2019. „Prähospitales Atemwegsmanagement“Google Scholar
  45. 45.
    Simons FE, Schatz M. Anaphylaxis during pregnancy. J Allergy Clin Immunol. 2012;130:597–606CrossRefPubMedGoogle Scholar
  46. 46.
    Choo KJ, Simons E, Sheikh A. Glucocorticoids for the treatment of anaphylaxis: Cochrane systematic review. Allergy 2010;65:1205–11CrossRefPubMedGoogle Scholar
  47. 47.
    Bresser H, Sander CH, Rakoski J. Insektenstichnotfälle in München. Allergo J. 1995;4:373–76Google Scholar
  48. 48.
    Mostmans Y, Grosber M, Blykers M, Mols P, Naeije N, Gutermuth J. Adrenalin in anaphylaxis treatment and self-administration: experiences from an inner city emergency department. Allergy. 2017;72:492–7CrossRefPubMedGoogle Scholar
  49. 49.
    Rueff F, Przybilla B, Bilo MB et al. Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity. J Allergy Clin Immunol. 2009;124:1047–54CrossRefPubMedGoogle Scholar
  50. 50.
    Przybilla B, Ruef F, Walker B et al. Diagnose und Therapie der Bienen- und Wespengiftallergie. Allergo Journal. 2011;20:318–39CrossRefGoogle Scholar
  51. 51.
    Brockow K, Przybilla B, Aberer W, Bircher AJ, Brehler R, Dickel H, Fuchs T, Jakob T, Lange L, Pfützner W, Mockenhaupt M, Ott H, Pfaar O, Ring J, Sachs B, Sitter H, Trautmann A, Treudler R, Wedi B, Worm M, Wurpts G, Zuberbier T, Merk HF. Guideline for the diagnosis of drug hypersensitivity reactions. Allergo J Int. 2015;24:94–105CrossRefPubMedPubMedCentralGoogle Scholar
  52. 52.
    Brockow K, Schallmayer S, Beyer K, Biedermann T, Fischer J, Gebert N, Grosber M, Jakob T, Klimek L, Kugler C, Lange L, Pfaar O, Przybilla B, Rietschel R, Rueff F, Schnadt S, Szczepanski R, Worm M, Kupfer J, Gieler U, Ring J. Effects of a structured educational intervention on knowledge and emergency management in patients at risk for anaphylaxis. Allergy. 2015;70:227–35CrossRefPubMedGoogle Scholar
  53. 53.
    Zuberbier T, Asero R, Bindslev-Jensen C et al. EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy. 2009;64:1427–43CrossRefPubMedGoogle Scholar
  54. 54.
    Guerlain S, Hugine A, Wang L. A comparison of 4 epinephrine autoinjector delivery systems: usability and patient preference. Ann Allergy Asthma Immunol. 2010;104:172–7CrossRefPubMedPubMedCentralGoogle Scholar
  55. 55.
    Simons FE, Gu X, Simons KJ. Outdated EpiPen and EpiPen Jr auto-injectors: past their prime? J Allergy Clin Immunol. 2000;105:1025–30CrossRefPubMedGoogle Scholar
  56. 56.
    Campbell RL, Bellolio MF, Motosue MS, Sunga KL, Lohse CM, Rudis MI. Autoinjectors preferred for intramuscular epinephrine in anaphylaxis and allergic reactions. West J Emerg Med. 2016;17:775–80CrossRefPubMedPubMedCentralGoogle Scholar
  57. 57.
    European Medicines Agency. Better training tools recommended to support patients using adrenalin auto-injectors. 26 June 2015 EMA/ 411622/2015Google Scholar
  58. 58.
    Ring J, Grosber M, Brockow K. Anaphylaxieerkennung, Notfallbehandlung und Management. Arzneimitteltherapie. 2016;34:112–9Google Scholar
  59. 59.
    Brockow et al. Versorgung von Patienten nach Anaphylaxie - Möglichkeiten und Defizite. Allergo J Int. (im Druck)Google Scholar
  60. 60.
    McNeil C, Copeland J. Accidental digital epinephrine injection: to treat or not to treat? Can Fam Physician 2014;60:726–8PubMedPubMedCentralGoogle Scholar
  61. 61.
    Ring J, Klimek L, Worm M. Adrenalin in der Akutbehandlung der Anaphylaxie. Dtsch Ärztebl Int. 2018;115:528–34PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2019

Authors and Affiliations

  • Johannes Ring
    • 1
    Email author
  • Andreas Weins
    • 1
  • Martine Grosber
    • 1
  • Knut Brockow
    • 1
  1. 1.Klinik und Poliklinik für Dermatologie und Allergologie am Biederstein der TU MünchenMünchenDeutschland

Personalised recommendations